You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1 to 25 of about 5638
Next 25
09/24/2023
Brain Tumors in United States Military Veterans
Peptide vaccine targets H3K27M mutation in midline gliomas, shows promise in early trials
09/18/2023
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
09/16/2023
FDA expands approval of Temodar to treat additional form of brain cancer
09/14/2023
Deep vein thrombosis as a side effect of cancer: 9 things to know??
xCures Platform advances progress on the White House Cancer Moonshot mission to end cancer as we know it.
09/11/2023
Cancer Chomp: A Brain Tumor Event in Gainesville, FL
Study shows how microdevices can be used to treat brain cancer
08/29/2023
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application
Journey of pediatric brain tumor tissue donation
08/26/2023
Update on the Promising Pathway Act
Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
Prodrug-loaded semiconducting polymer hydrogels for deep-tissue sono-immunotherapy of orthotopic glioblastoma
08/23/2023
Estrogen-negative cancers respond to anti-estrogenic therapies
08/19/2023
Optune Open House in Tarrytown, NY Sept 12th, 2023.
08/18/2023
Using the Body’s `Invisible Scalpel` to Remove Brain Cancer With Immunotherapy at Salk Institute
Scientists Find New Weapon Against Brain Tumor: `Major Crack in the Armor`
08/12/2023
Plus Therapeutics Reports ReSPECT-LM Phase 1 Trial Data at the 2023 SNO/ASCO CNS Cancer Conference
She went to Germany for a new brain cancer treatment. She wonders why she had to learn about it online
08/10/2023
Perlmutter Cancer Center Enrolls First Participant in Study of Noninvasive Treatment of Glioblastoma
08/07/2023
GT Medical Technologies Marks a Clinical Milestone: 200th Patient Enrolled in the Multicenter Observational Registry of GammaTile® Therapy
08/02/2023
Phase 1 clinical trial underway to test City of Hope-developed cancer treatment
07/27/2023
Musella Foundation Copay Program now closed to new and renewal patients
07/26/2023
Hackensack Meridian Neuroscience Institute Now Using QuicktomeTM Brain Mapping Technology To Maximize Patient Outcomes By Allowing Neurosurgeons To Visualize Key Areas of the Brain Related To Speech and Other Key Functions During Complex Brain Surgery
United States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma